.png){kind=icon}
.png){kind=icon}
Return
Impact of early intensive GDMT on LVEF recovery and ICD decision making in de novo HFrEF
.png){kind=icon}
OA
AI
D
D
J
R
J
D
N
F
D
J
DOI：10.1002/ehf2.15443.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Implantable cardioverter-defibrillator (ICD) implantation is recommended in patients with heart failure with reduced ejection fraction (HFrEF) and left ventricular ejection fraction (LVEF) ≤ 35% after 3 months of optimized medical therapy (OMT). Whether recent advances in guideline-directed medical therapy (GDMT), including angiotensin receptor-neprilysin inhibitors (ARNI) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) alter the timing of ICD implantation remains uncertain.
Keywords:
heart failure
ICD
GDMT
LVEF
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.7
Papers:
3.3K
Citations:
9.1K
Organization
Cited Papers